Stay updated on Efficacy of Rifaximin with NAC in IBS-D Clinical Trial

Sign up to get notified when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and Revision: v3.4.2 removed. No visible changes to study content or functionality are indicated.
    Difference
    0.0%
    Check dated 2026-03-12T01:45:59.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-status notice and the older Revision: v3.4.1 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T13:58:55.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding notice was added and the page revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:59:32.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates include a glossary toggle and the display of QC-related metadata (Last Update Submitted that Met QC Criteria) and the site revision version (v3.4.0); these changes affect presentation rather than core study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:39:33.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:25:26.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new Locations section has been added, listing California as a study site (Los Angeles, CA). The page's references to California Locations and the HHS Vulnerability Disclosure link were removed in revision 3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:37:27.000Z thumbnail image

Stay in the know with updates to Efficacy of Rifaximin with NAC in IBS-D Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.